Randomized Phase III Trial of High–Dose-Intensity Methotrexate, Vinblastine, Doxorubicin, and Cisplatin (MVAC) Chemotherapy and Recombinant Human Granulocyte Colony-Stimulating Factor Versus Classic MVAC in Advanced Urothelial Tract Tumors: European Organization for Research and Treatment of Cancer Protocol No. 30924Cora N. Sternberg, Laurence Collette, Jan H. Schornagel et al.|Journal of Clinical Oncology|2001Cited by 628
Advanced seminoma—Treatment results and prognostic factors for survival after first‐line, cisplatin‐based chemotherapy and for patients with recurrent diseaseDany Gholam, Christine Théodore|Cancer|2003Cited by 64